Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

As part of its renewed commitment, the Alan Davidson Foundation will continue to fund a full-time project manager to facilitate the ongoing coordination and growth of the ACORN study. The foundation is also contributing to the cost of a research fellow to support the next phase of the project.

Motor neuron disease researchers in a lab © NDCN Oxford

The Alan Davidson Foundation has renewed its generous commitment to motor neuron disease (MND) research at Oxford by supporting the ACORN study for a further three years. This renewed funding builds on the foundation’s original donation in 2021

The ACORN study, led by the Oxford Motor Neuron Disease Centre in the Nuffield Department of Clinical Neurosciences and supported by Oxford University Hospitals through the NIHR Biomedical Research Centre, focuses on individuals with a genetic predisposition to MND and frontotemporal dementia (FTD). The project aims to detect early biological changes that occur before the onset of symptoms, contributing to a deeper understanding of these devastating conditions and improving the chances of early interventions.

The Alan Davidson Foundation was founded in 2015 by the late Alan Hayes Davidson RIBA, a pioneer in architectural illustration and visualisation. Diagnosed with MND in 2012, Alan dedicated the final years of his life to supporting research and improving palliative care. He established the foundation to ensure long-term support for initiatives in these fields, as well as in architecture. Since his death in 2018, the foundation has ensured the continued impact of Alan’s legacy through strategic grant-making and partnerships, particularly in the area of MND research.

Read the full story on the Nuffield Department of Clinical Neurosciences website

Similar stories

Exceptional early-career researchers awarded 2026 European Research Council Starting Grants

Four University of Oxford researchers have been awarded prestigious European Research Council (ERC) Starting Grants, each worth €1.5 million for a period of up to five year

How body fat is stored across organs may reveal hidden health risks, study suggests

Researchers from the Nuffield Department of Population Health and the University of Oxford’s Big Data Institute have contributed to a new study showing that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.

Four Oxford researchers recognised in the 2026 Royal Society Awards

The annual Royal Society Awards recognise outstanding contributions to scientific discovery, public engagement and research culture. Of the 27 awards for 2025-26, announced today, four honour Oxford University researchers.

New shingles vaccine linked to lower risk of coronary heart disease, stroke and heart failure – major study indicates

The shingles vaccine currently in use, called ‘Shingrix’, is associated with a reduced risk of cardiovascular events – including heart attacks, heart failure and stroke – compared to the previous shingles vaccine, according to a major new study published in Nature Medicine.

Vapes help more people quit smoking than other methods, Oxford-led Cochrane review finds

An updated Cochrane review led by Oxford researchers finds nicotine e-cigarettes help more people quit smoking than nicotine patches and gum, behavioural support or no support. The living review now includes 80 trials and nearly 30,000 participants.

Brain imaging study reveals how we decide whether we are in control

A brain imaging and stimulation study led by the University of Oxford has identified the brain mechanisms that help us work out whether the consequences we experience are caused by our own actions or by circumstances beyond our control.